Topics

"Prevail licenses REGENXBIO AAV9 gene delivery technology neurodegenerative" Drugs and Medication Database: Page 2

02:44 EST 21st November 2019 | BioPortfolio

Here are the most relevant "Prevail licenses REGENXBIO AAV9 gene delivery technology neurodegenerative" Drugs and Medications that we have found in our database.

More Information about "Prevail licenses REGENXBIO AAV9 gene delivery technology neurodegenerative" on BioPortfolio

We have published hundreds of Prevail licenses REGENXBIO AAV9 gene delivery technology neurodegenerative news stories on BioPortfolio along with dozens of Prevail licenses REGENXBIO AAV9 gene delivery technology neurodegenerative Clinical Trials and PubMed Articles about Prevail licenses REGENXBIO AAV9 gene delivery technology neurodegenerative for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prevail licenses REGENXBIO AAV9 gene delivery technology neurodegenerative Companies in our database. You can also find out about relevant Prevail licenses REGENXBIO AAV9 gene delivery technology neurodegenerative Drugs and Medications on this site too.

Showing "Prevail licenses REGENXBIO AAV9 gene delivery technology neurodegenerative" Drugs and Medications 26–38 of 38

Possibly Relevant

Drytec (technetium tc99m generator) [medi-physics inc.]

Drytec™ (Technetium Tc99m Generator) For the Production of Sodium Pertechnetate Tc99m Injection

Xofigo [bayer healthcare pharmaceuticals inc.]

These highlights do not include all the information needed to use XOFIGO safely and effectively. See full prescribing information for XOFIGO. XOFIGO (radium Ra 223 dichloride) injection, for intravenous useInitial U.S. Approval: 2013

Oxygen [praxair distribution, inc.]

Oxygen

Endometrin [ferring pharmaceuticals inc.]

These highlights do not include all the information needed to use ENDOMETRIN safely and effectively. See full prescribing information for ENDOMETRIN. ENDOMETRIN (progesterone) Vaginal Insert 100 mg Initial U.S. Approval: 2007

Xtandi [astellas pharma us, inc.]

These highlights do not include all the information needed to use XTANDI safely and effectively. See full prescribing information for XTANDI.XTANDI (enzalutamide) capsules, for oral useInitial U.S. Approval: 2012

Indiclor [medi-physics inc.]

INDICLOR™

Clonidine hydrochloride [carlsbad technology, inc]

Clonidine Hydrochloride Tablets, USP

R-gene [pharmacia and upjohn company llc]

R-Gene 10Arginine Hydrochloride Injection, USP

Salvax [exeltis usa dermatology, llc]

SALVAX

Testo-100 [advanced pharmaceutical technology, inc.]

Testo-100

Klor-con m [sandoz inc.]

KLOR-CON M Potassium Chloride Extended-Release Tablets, USP 10 mEq, 15 mEq, and 20 mEq MICRO-DISPERSIBLE TECHNOLOGY

Aimovig [amgen inc]

These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018

Emgality [eli lilly and company]

These highlights do not include all the information needed to use EMGALITY safely and effectively. See full prescribing information for EMGALITY.EMGALITY (galcanezumab-gnlm) injection, for subcutaneous useInitial U.S. Approval: 2018



Quick Search